Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
Browsing: study
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Bavarian Nordic stock slides on Moderna mpox vaccine study Source: Seekingalpha
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
Neurocrine stock dips even as schizophrenia drug meets main goal in study Source: Seekingalpha
Delcath stock jumps 15% on Hepzato Kit study publication Source: Seekingalpha